导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.26% | 607/1050 |
| 近一周 | -3.78% | 956/1104 |
| 近一月 | -8.65% | 970/1102 |
| 近一季 | -6.07% | 654/1092 |
| 近半年 | 2.67% | 374/1070 |
| 近一年 | 1.43% | 568/1018 |
| 近两年 | 71.80% | 352/926 |
| 近三年 | 50.21% | 255/833 |
| 成立以来 | 126.61% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.93% 969/1070 |
46.81% 241/1101 |
- - |
- - |
| 2025 | 37.89% 351/1065 |
8.18% 219/1014 |
2.45% 472/1038 |
30.10% 356/1050 |
-4.36% 685/1065 |
| 2024 | 24.27% 55/1011 |
3.74% 142/960 |
0.28% 288/983 |
15.46% 204/991 |
3.45% 182/1011 |
| 2023 | -20.62% 686/952 |
0.44% 609/880 |
-9.26% 742/895 |
-4.38% 260/915 |
-8.92% 806/952 |
| 2022 | -18.02% 256/867 |
-10.23% 113/773 |
7.30% 386/806 |
-12.21% 403/845 |
-3.05% 580/867 |
| 2021 | -2.38% 385/740 |
0.56% 129/580 |
6.58% 436/659 |
-8.02% 450/704 |
-0.97% 481/740 |
| 2020 | 71.73% 138/554 |
-4.41% 270/419 |
24.96% 192/466 |
13.03% 178/517 |
27.20% 49/554 |
| 2019 | 59.88% 83/410 |
27.15% 535/1146 |
1.60% 197/1228 |
9.84% 113/390 |
12.67% 101/410 |
| 2018 | - - |
- - |
-3.05% 142/990 |
-5.81% 498/1000 |
-12.18% 610/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 建信龙头企业股票 VS. 东吴新产业精选股票A(580008) |